Erratum: Thioredoxin: friend or foe in human disease? (Trends Pharmacological Sciences (2005) 26 (398-404) DOI: 10.1016/j.tips.2005.06.005);Thioredoxin: Friend or foe in human disease?

Trends in Pharmacological Sciences

Volumn 26, Issue 8, 2005, Pages 398-404

  Burke Gaffney, Anne ^a   Callister, Matthew E J ^a   Nakamura, Hajime ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLHYDROXYPROPYL 2 IMIDAZOLOYL DISULFIDE; 1,4 NAPHTHOQUINONE DERIVATIVE; 4 HYDROXY 4 (BENZOTHIAZOL 2 YL)CYCLOHEXADIENONE; ALCOHOL DERIVATIVE; AW 464; CHEMOKINE; CYSTEINE; DISULFIDE; METHYL 4 HYDROXY 4 (8 METHYL 1,2 DIOXO 2 PHENYL 2,3,5,8 TETRAHYDRO 1H [1,2,4]TRIAZOLO[1,2 A]PYRIDAZIN 5 YL) 2 BUTYNOATE; MOL 294; ORGANIC COMPOUND; PALMARUMYCIN CP 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PX 12; RECOMBINANT PROTEIN; REGULATOR PROTEIN; TEMOCAPRIL; TEPRENONE; THIOREDOXIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

AGING; APOPTOSIS; BACTERIUM; BIODIVERSITY; BIOLOGICAL ACTIVITY; BRAIN ISCHEMIA; CANCER; CANCER GROWTH; CARCINOGENESIS; CELL ACTIVITY; CELL FUNCTION; CELL GROWTH; CELL INFILTRATION; CELL MIGRATION; CELL PROTECTION; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; INTERSTITIAL LUNG DISEASE; ISCHEMIA; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PERINATAL DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; TUMOR; ULCER; UPREGULATION; VIRUS INFECTION;

EID: 22844442461     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2005.11.004     Document Type: Erratum

References (79)

1. L. Tao Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation Proc. Natl. Acad. Sci. U. S. A. 101 2004 11471 11476
2. G. Powis The role of the redox protein thioredoxin in cell growth and cancer Free Radic. Biol. Med. 29 2000 312 322
3. S. Gromer The thioredoxin system-from science to clinic Med. Res. Rev. 24 2004 40 89
4. H. Masutani Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection Mol. Neurobiol. 29 2004 229 242
5. H. Nakamura Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS Proc. Natl. Acad. Sci. U. S. A. 98 2001 2688 2693
6. E.S. Arner, and A. Holmgren Physiological functions of thioredoxin and thioredoxin reductase Eur. J. Biochem. 267 2000 6102 6109
7. G. Powis, and W.R. Montfort Properties and biological activities of thioredoxins Annu. Rev. Pharmacol. Toxicol. 41 2001 261 295
8. K. Becker Thioredoxin reductase as a pathophysiological factor and drug target Eur. J. Biochem. 267 2000 6118 6125
9. R.P. Hirt The diversity and evolution of thioredoxin reductase: new perspectives Trends Parasitol. 18 2002 302 308
10. A.K. Rundlof, and E.S. Arner Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events Antioxid. Redox Signal. 6 2004 41 52
11. Y. Kabe Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus Antioxid. Redox Signal. 7 2005 395 403
12. S.J. Wei Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation Cancer Res. 60 2000 6688 6695
13. W.H. Watson Thioredoxin and its role in toxicology Toxicol. Sci. 78 2004 3 14
14. K.C. Das Thioredoxin system in premature and newborn biology Antioxid. Redox Signal. 6 2004 177 184
15. J. Haendeler Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69 Nat. Cell Biol. 4 2002 743 749
16. B. Husbeck Increased thioredoxin-1 inhibits SSAT expression in MCF-7 human breast cancer cells Biochem. Biophys. Res. Commun. 306 2003 469 475
17. J. Nordberg, and E.S. Arner Reactive oxygen species, antioxidants, and the mammalian thioredoxin system Free Radic. Biol. Med. 31 2001 1287 1312
18. H. Nakamura Thioredoxin as a key molecule in redox signaling Antioxid. Redox Signal. 6 2004 15 17
19. R. Bertini Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells J. Exp. Med. 189 1999 1783 1789
20. H. Nakamura Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis Proc. Natl. Acad. Sci. U. S. A. 98 2001 15143 15148
21. K. Pekkari, and A. Holmgren Truncated thioredoxin: physiological functions and mechanism Antioxid. Redox Signal. 6 2004 53 61
22. D.T. Lincoln The thioredoxin-thioredoxin reductase system: over-expression in human cancer Anticancer Res. 23 2003 2425 2433
23. J. Raffel Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival J. Lab. Clin. Med. 142 2003 46 51
24. S.J. Welsh The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis Cancer Res. 62 2002 5089 5095
25. E.J. Meuillet Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity Arch. Biochem. Biophys. 429 2004 123 133
26. M. Pallis Induction of apoptosis without redox catastrophe by thioredoxin-inhibitory compounds Biochem. Pharmacol. 66 2003 1695 1705
27. S.J. Welsh The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation Mol. Cancer Ther. 2 2003 235 243
28. H. Nakamura Redox imbalance and its control in HIV infection Antioxid. Redox Signal. 4 2002 455 464
29. R. Breitkreutz Massive loss of sulfur in HIV infection AIDS Res. Hum. Retroviruses 16 2000 203 209
30. L.J. Matthias Disulfide exchange in CD4 Biofactors 17 2003 241 248
31. T. Turoczi Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1 J. Mol. Cell. Cardiol. 35 2003 695 704
32. K. Kasuno Protective roles of thioredoxin, a redox-regulating protein, in renal ischemia/reperfusion injury Kidney Int. 64 2003 1273 1282
33. D.K. Das Thioredoxin regulation of ischemic preconditioning Antioxid. Redox Signal. 6 2004 405 412
34. I. Hattori Intravenous administration of thioredoxin decreases brain damage following transient focal cerebral ischemia in mice Antioxid. Redox Signal. 6 2004 81 87
35. D.G. Souza NF-kappaB plays a major role during the systemic and local acute inflammatory response following intestinal reperfusion injury Br. J. Pharmacol. 145 2005 246 254
36. M. Miyamoto Thioredoxin, a redox-regulating protein, is expressed in spontaneous myocarditis in inbred strains of mice Int. J. Cardiol. 95 2004 315 319
37. W. Liu Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice Circulation 110 2004 1276 1283
38. M. Yamamoto Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy J. Clin. Invest. 112 2003 1395 1406
39. J. Yoshioka Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity Circulation 109 2004 2581 2586
40. C. Kishimoto Serum thioredoxin (TRX) levels in patients with heart failure Jpn. Circ. J. 65 2001 491 494
41. M. Tanito Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats Antioxid. Redox Signal. 6 2004 89 97
42. T. Yoshida The role of thioredoxin in the aging process: involvement of oxidative stress Antioxid. Redox Signal. 5 2003 563 570
43. E.R. Stadtman Oxidation of methionine residues of proteins: biological consequences Antioxid. Redox Signal. 5 2003 577 582
44. J. Bai Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells J. Neurosci. 23 2003 503 509
45. M. Kobayashi-Miura Thioredoxin, an anti-oxidant protein, protects mouse embryos from oxidative stress-induced developmental anomalies Free Radic. Res. 36 2002 949 956
46. B.F. Jordan The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging Clin. Cancer Res. 11 2005 529 536
47. L.D.T. Kirkpatrick Results from a Phase I study of PX-12, a thioredoxin inhibitor in patients with advanced solid malignancies Proc. Am. Assoc. Clin. Oncol. 22 2004 217
48. A. Baker Pharmacodynamic proteomic studies of the thioredoxin-1 inhibitor PX-12 in mice and patients Proc Am Assoc Clin Oncol 22 2004 3662
49. P. Wipf New inhibitors of the thioredoxin-thioredoxin reductase system based on a naphthoquinone spiroketal natural product lead Bioorg. Med. Chem. Lett. 11 2001 2637 2641
50. P. Wipf Natural product based inhibitors of the thioredoxin-thioredoxin reductase system Org. Biomol. Chem. 2 2004 1651 1658
51. A. Mukherjee Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study Br. J. Cancer 92 2005 350 358
52. G. Wells 4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell lines J. Med. Chem. 46 2003 532 541
53. J.M. Berry Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents J. Med. Chem. 48 2005 639 644
54. T.D. Bradshaw Elucidation of thioredoxin as a molecular target for antitumor quinols Cancer Res. 65 2005 3911 3919
55. A. Misra-Press Identification of a novel inhibitor of the NF kappa B pathway Curr. Med. Chem. 1 2002 29
56. W.R. Henderson Jr A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model J. Immunol. 169 2002 5294 5299
57. K. Hirota Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes Biochem. Biophys. Res. Commun. 275 2000 825 830
58. J. Bai Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells Neurosci. Lett. 321 2002 81 84
59. S. Kikuchi Effect of geranylgeranylaceton on cellular damage induced by proteasome inhibition in cultured spinal neurons J. Neurosci. Res. 69 2002 373 381
60. Z. Yuan Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression Mol. Cell. Biochem. 248 2003 185 192
61. T. Hoshino Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury Am. J. Respir. Crit. Care Med. 168 2003 1075 1083
62. N. Kondo Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops J. Immunol. 172 2004 442 448
63. H. Nakamura Elevation of plasma thioredoxin levels in HIV-infected individuals Int. Immunol. 8 1996 603 611
64. K. Miyazaki Elevated serum level of thioredoxin in patients with hepatocellular carcinoma Biotherapy 11 1998 277 288
65. H. Nakamura Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery Free Radic. Biol. Med. 24 1998 1176 1186
66. M.M. Maurice Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis Arthritis Rheum. 42 1999 2430 2439
67. S. Yoshida Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha-induced production of IL-6 and IL-8 from cultured synovial fibroblasts J. Immunol. 163 1999 351 358
68. A. Abdiu Thioredoxin blood level increases after severe burn injury Antioxid. Redox Signal. 2 2000 707 716
69. T. Koura Expression of thioredoxin in granulomas of sarcoidosis: possible role in the development of T lymphocyte activation Thorax 55 2000 755 761
70. H. Nakamura Expression of thioredoxin and glutaredoxin, redox-regulating proteins, in pancreatic cancer Cancer Detect. Prev. 24 2000 53 60
71. Y. Sumida Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection J. Hepatol. 33 2000 616 622
72. T. Jikimoto Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis Mol. Immunol. 38 2002 765 772
73. Y. Kakisaka Elevation of serum thioredoxin levels in patients with type 2 diabetes Horm. Metab. Res. 34 2002 160 164
74. Y. Yamada Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma Immunol. Lett. 86 2003 199 205
75. A. Kato Elevation of blood thioredoxin in hemodialysis patients with hepatitis C virus infection Kidney Int. 63 2003 2262 2268
76. M.E.J. Callister Thioredoxin concentrations are elevated in plasma and bronchoalveolar lavage fluid from patients with acute lung injury Am. J. Respir. Crit. Care Med. 167 2003 A662
77. K. Miwa Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina Clin. Cardiol. 26 2003 177 181
78. S. Miyamoto Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction Am. Heart J. 146 2003 465 471
79. A. Jekell Elevated circulating levels of thioredoxin and stress in chronic heart failure Eur. J. Heart Fail. 6 2004 883 890